Comparison of renal prognosis between dipeptidyl peptidase-4 inhibitor users and non-users.

Hideaki HashimotoMichihiro SatohShingo NakayamaMaya ToyamaTakahisa MurakamiTaku ObaraNaoki NakayaTakefumi MoriAtushi HozawaHirohito Metoki

Published in: Diabetes, obesity & metabolism (2024)

This retrospective real-world study revealed that patients using DPP-4is had a better renal prognosis than those not using DPP-4is.